Sector Gamma AS
- SEC CIK
- 0001475373
- Latest filing
- Aug 12, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 8, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 33
- +4 vs. Q3 2021
- Portfolio value
- $425.4M
- −$75.9M (−15.1%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MRKMerck & Co., Inc. | Stock | 475,804 | $36.5M | 8.6% | −337,010−41.5% | Reduced | History |
| INCYIncyte Corp | COM | 378,852 | $27.8M | 6.5% | +76,113+25.1% | Added | History |
| CAHCardinal Health Inc | Stock | 496,680 | $25.6M | 6.0% | −26,926−5.1% | Reduced | History |
| BMYBristol Myers Squibb Co | Stock | 348,591 | $21.7M | 5.1% | −96,419−21.7% | Reduced | History |
| GILDGilead Sciences, Inc. | Stock | 297,055 | $21.6M | 5.1% | −74,030−19.9% | Reduced | History |
| CVSCVS Health Corp | Stock | 206,162 | $21.3M | 5.0% | +30,042+17.1% | Added | History |
| BSXBoston Scientific Corp | Stock | 499,530 | $21.2M | 5.0% | −103,152−17.1% | Reduced | History |
| MDTMedtronic plc | Stock | 204,268 | $21.1M | 5.0% | +19,568+10.6% | Added | History |
| BDXBecton Dickinson & Co | Stock | 75,647 | $19.0M | 4.5% | −5,946−7.3% | Reduced | History |
| PFEPfizer Inc | Stock | 285,403 | $16.9M | 4.0% | −366,197−56.2% | Reduced | History |
| BIIBBiogen Inc. | COM | 66,599 | $16.0M | 3.8% | −16,720−20.1% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 34,402 | $15.9M | 3.7% | −8,790−20.4% | Reduced | History |
| CNCCentene Corp | Stock | 183,146 | $15.1M | 3.5% | −29,077−13.7% | Reduced | History |
| BRKRBruker Corp | COM | 162,768 | $13.7M | 3.2% | −70,484−30.2% | Reduced | History |
| OGNOrganon & Co. | Stock | 431,709 | $13.1M | 3.1% | −114,353−20.9% | Reduced | History |
| NUVANuvasive Inc | COM | 240,691 | $12.6M | 3.0% | −57,735−19.3% | Reduced | History |
| QGENQiagen N.V. | SHS NEW | 196,845 | $10.9M | 2.6% | −133,375−40.4% | Reduced | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 113,548 | $10.0M | 2.4% | +113,548 | New | History |
| ELANElanco Animal Health Inc | COM | 345,230 | $9.80M | 2.3% | −64,501−15.7% | Reduced | History |
| CICigna Group | Stock | 41,500 | $9.53M | 2.2% | +41,500 | New | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 11,639 | $8.79M | 2.1% | +384+3.4% | Added | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 39,069 | $8.58M | 2.0% | +39,069 | New | History |
| LHLabcorp Holdings Inc. | COM NEW | 23,377 | $7.34M | 1.7% | −14,481−38.3% | Reduced | History |
| XRAYDentsply Sirona Inc. | Stock | 114,816 | $6.41M | 1.5% | −136,514−54.3% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 209,537 | $6.38M | 1.5% | −54,333−20.6% | Reduced | History |
| UHSUniversal Health Services Inc | CL B | 45,238 | $5.87M | 1.4% | −5,057−10.1% | Reduced | History |
| SAGESage Therapeutics, Inc. | COM | 98,904 | $4.21M | 1.0% | −11,863−10.7% | Reduced | History |
| RIGLRigel Pharmaceuticals Inc | COM NEW | 1,469,604 | $3.89M | 0.9% | −303,126−17.1% | Reduced | History |
| MRTXMirati Therapeutics, Inc. | COM | 26,106 | $3.83M | 0.9% | +106+0.4% | Added | History |
| PDCOPatterson Companies, Inc. | COM | 122,947 | $3.61M | 0.8% | −47,600−27.9% | Reduced | History |
| BNTXBioNTech SE | SPONSORED ADS | 13,032 | $3.36M | 0.8% | +13,032 | New | History |
| NVAXNovavax Inc | COM NEW | 13,346 | $1.91M | 0.4% | +2,302+20.8% | Added | History |
| VIRVir Biotechnology, Inc. | COM | 44,000 | $1.84M | 0.4% | +44,000 | New | History |
Sold out since Q3 2021 (1)
Positions held at the end of Q3 2021 that are gone from this filing.